Further Updates on Aculabs’ New York Expansion

Last month, Aculabs announced that it would begin undergoing the process to expand the reach of its clinical lab services into New York. This process included an on-site inspection with New York State in late November. Following completion of the inspection, we begin the next phase of waiting for New York's decision. Aculabs first took interest

By |2018-12-10T10:23:17-05:00December 7th, 2018|Categories: News|0 Comments

Caring for Geriatric Populations and Preparing for Flu Season

Seasonal spikes in illnesses have been observed for centuries, with influenza spiking in winter being a commonly observed occurrence. According to the Center for Disease Control and Prevention, influenza viruses see a spike in detection from December to March. In a 36-year-period, the CDC observed that flu activity most often peaked in February followed by

By |2018-11-12T16:08:31-05:00November 12th, 2018|Categories: News|0 Comments

Aculabs, Inc. Moves Forward With New York State Expansion

As the landscape of long-term care begins to change, nursing homes and their long-standing relationships with laboratory service providers ultimately change as well. There is a growing industry need for laboratories who can offer well-rounded service at competitive prices. Aculabs' resident-centered service prioritizes patient comfort and dignity. Our approach to clinical laboratory service emphasizes the need for

By |2018-10-31T10:22:35-04:00October 31st, 2018|Categories: News|0 Comments

Letter from the Director: Biotin Influence on Laboratory Immunoassay Tests

Published September 2018 as part of Aculabs' LabTalk quarterly newsletter. Laboratory errors have been reported to be 0.012-0.6%; errors due to interference are less than 0.078%. One of the causes of interference in a laboratory is Biotin. - National Institutes of Health's Office of Dietary Supplements. Biotin, known as vitamin B7 or vitamin

By |2020-12-29T15:50:20-05:00September 25th, 2018|Categories: Quarterly Letter|0 Comments

Aculabs goes live with first Cobas e 801 module in New Jersey

As a leader in the post-acute care industry, Aculabs is always searching for new approaches to traditional lab services. Throughout our 45+ years of clinical laboratory service, we’ve proven ourselves as eager to embrace the most cutting-edge technology within our reach. We’ve written in the past about how our laboratory features some of the finest

By |2018-09-17T15:35:32-04:00September 17th, 2018|Categories: News|0 Comments

Recognizing & responding to human trafficking in a healthcare context

As an industry that experiences frequent and intimate contact with the general public, healthcare professionals have a scrupulous expectation of workplace ethics. Being some of the few individuals whom human trafficking victims may interact with, there is a growing call to action for those within healthcare to know how to recognize and respond to

By |2018-09-17T14:49:15-04:00September 12th, 2018|Categories: News|0 Comments

Letter from the Director: Postural Pseudoanemia in Long-Term Care Facilities

Published July 2018 as part of Aculabs' LabTalk quarterly newsletter. Anemia is very common in the geriatric population; several studies have shown that the prevalence of anemia increases with advancing in age, the increase start at the age of 65 and rises sharply after the age of 80. To diagnose anemia, physicians rely heavily on

By |2018-09-25T12:41:21-04:00July 26th, 2018|Categories: Quarterly Letter|0 Comments

Medical necessity & overutilization in the age of online ordering

Online transactions are one of the most fundamental ways people's interactions with one another have changed over the past few years. At one point in time, ordering a blood test could take significantly longer, often taking several weeks. With technology, automation and the implementation of ordering systems, more power is back in the hands of

By |2021-08-16T12:51:24-04:00June 27th, 2018|Categories: News|0 Comments

Understanding CMS Guidelines: Advanced Beneficiary Notices, Frequency Limitations & Non-Covered Tests

The Centers for Medicare & Medicaid Services (CMS) hold well-established guidelines regarding what is considered medically necessary within the realm of testing. Medical necessity is important in clinical testing because tests deemed to fall out of the definition of being medically necessary can end up being denied by CMS for reimbursement. As well, CMS has

By |2018-06-26T12:54:11-04:00June 26th, 2018|Categories: News|0 Comments

Aculabs Point of Care Program results in 30% reduction of hospital readmission rate

Early last week, we received Interact data from a number of facilities participating in our Point of Care Program.  Analyzing a 12 month period, the 30-Day Readmission Rate has shown significant improvement.  Facilities experienced a decrease of 30% in the Post-Acute hospital readmission rate. History Aculabs began developing its Point of Care Program in

By |2019-01-29T13:09:21-05:00May 23rd, 2018|Categories: News|0 Comments
Go to Top